Results 201 to 210 of about 273,369 (310)

Assessment of central blood volume in cirrhosis by radionuclide angiography [PDF]

open access: yes, 1994
Bendtsen, Flemming   +10 more
core  

Somatostatin receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE/-TOC uptake.

open access: yesNeuro-Oncology, 2016
K. Seystahl   +11 more
semanticscholar   +1 more source

Astatine‐211—Towards In Vivo Stable Astatine‐211 Labeled Radiopharmaceuticals and Their (Pre)Clinical Applications

open access: yesMedicinal Research Reviews, Volume 46, Issue 1, Page 203-237, January 2026.
ABSTRACT Targeted radioligand therapy has emerged as a promising treatment option for eradicating advanced cancer forms. α‐Emitters are considered particularly promising as they can obliterate (micro)‐metastases. The α‐emitter astatine‐211 (211At) has experienced increased interest due to its favorable decay properties.
Marius Müller   +5 more
wiley   +1 more source

Production of 177Lu for Targeted Radionuclide Therapy: Available Options

open access: yesNuclear medicine and molecular imaging, 2015
A. Dash, M. Pillai, F. Knapp
semanticscholar   +1 more source

High‐Loaded Bismuth Oxide/Copper Silicone Rubber Composites and Their Application as Shielding Collar for I‐131 Treated Thyroid Cancer Patients

open access: yesSPE Polymers, Volume 7, Issue 1, January 2026.
Development of high‐filler‐content silicone rubber composites containing up to 80 wt% bismuth oxide or copper, demonstrating significant I‐131 attenuation with retained flexibility and durability. ABSTRACT The development of flexible, non‐lead radiation‐shielding materials remains a critical challenge, particularly for I‐131 protection, where no ...
Kanaungnit Kingpetch   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy